[Abstract] To achieve the C-terminal tagging of endogenous proteins in T. cruzi we use the Cas9/pTREX-n vector (Lander et al., 2015) to insert a specific tag sequence (3xHA or 3xc-Myc) at the 3' end of a specific gene of interest (GOI). Chimeric sgRNA targeting the 3' end of the GOI is PCR-amplified and cloned into Cas9/pTREX-n vector. Then a DNA donor molecule to induce DNA repair by homologous recombination is amplified. This donor sequence contains the tag sequence and a marker for antibiotic resistance, plus 100 bp homology arms corresponding to regions located right 
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4. Quantify isolated DNA fragments using a NanoDrop spectrophotometer.
5. Perform ligation reaction by mixing the following reagents in a 0.6 ml tube: 100 ng vector and 22 ng insert (20:1 insert to vector molar ratio), T4 DNA ligase (3 U), 2x rapid ligation buffer (1/2 of the final reaction volume) and completing the final volume to 10 μl with ultrapure water.
Incubate the reaction overnight at 4 °C.
6. Use 5 μl of the ligation product to transform chemically competent DH5α E. coli cells following standard heat-shock transformation protocol.
7. Spread cells on LB-agar plates supplemented with 100 μg/ml ampicillin and incubate overnight at 37 °C.
www.bio-protocol.org/e2299 Positive clones with sgRNA inserted in the right orientation amplify a band of 190 bp ( Figure 3 ). Forward ultramer will be as follows: 5'-HR1-GGTACCGGGCCCCCCCTCGAG-3'. Reverse ultramer will be as follows: 5'-HR2rc-TGGCGGCCGCTCTAGAACTAGTGGAT-3'.
2. Amplify the DNA donor containing the tag sequence and a marker for antibiotic resistance, plus 100 bp homology arms using pMOHX1Tag4H vector (for 3xHA tagging and hygromycin www.bio-protocol.org/e2299 3. Analyze PCR product on agarose gel. PCR product size: 1.5 kb (using pMOTag23M as template) (Figure 6 ) or 1.6 kb (using pMOHX1Tag4H as template). 
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containing 10% heat-inactivated FBS and penicillin (100 U/ml)/streptomycin (100 μg/ml) at 28 °C (Bone and Steinert, 1956 ).
Determine cell density of T. cruzi cultures by counting cells in a Neubauer chamber. T. cruzi
epimastigotes should be manipulated in biological safety cabinets.
F. Cell transfections 1. Co-transfect T. cruzi epimastigotes with sgRNA/Cas9/pTREX-n plasmid and DNA donor cassette for gene tagging. Perform transfections in triplicates.
2. Grow T. cruzi epimastigotes to a density of 1-2 x 10 7 cells/ml. 6. Keep cells in cuvette on ice for 10 min and then electroporate using a Bio-Rad Gene Pulser Xcell TM system set at 1.5 kV and 25 μF with 3 pulses, leaving cuvettes for 1 min on ice between pulses. Video 1 shows the standard electroporation procedure described in this protocol.
Video 1. Electroporation of T. cruzi epimastigotes
7. Let cells recover in cuvette at room temperature for 15 min.
8. Transfer cells to 5 ml LIT media supplemented with 20% heat-inactivated fetal bovine serum and incubate at 28 °C.
9. After 24 h, add antibiotics for selection. Antibiotics concentration should be previously optimized for each particular T. cruzi strain. For Y strain, cell lines should be maintained in medium containing 250 μg/ml G418 and 5 μg/ml puromycin (3xc-Myc tagged) or 250 μg/ml G418 and 350 μg/ml hygromycin (3xHA tagged). www.bio-protocol.org/e2299 
